“Class action suit rules tightened in SCC Pharma case” by Luis Milan, The Bottom Line
The Bottom Line quotes Pierre Lefebvre, a partner and litigator at Fasken Martineau’s office in Montreal, in an article about the Supreme Court of Canada’s decision to dismiss the proposed securities class action against Therathechnologies Inc. The article also examines the repercussions the SCC ruling may have on similar lawsuits in the future.